IMR Press / CEOG / Volume 30 / Issue 4 / pii/2003049

Clinical and Experimental Obstetrics & Gynecology (CEOG) is published by IMR Press from Volume 47 Issue 1 (2020). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on imrpress.com as a courtesy and upon agreement with S.O.G.

Original Research

An evaluation of the efficacy of using oocyte donors aged 36-39

Show Less
1 The University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School at Camden, Cooper Hospital/University Medical Center, Department of Obstetrics and Gynecology, Division of Reproductive Endocrinology & Infertility, Camden, NJ (USA)
Clin. Exp. Obstet. Gynecol. 2003, 30(4), 201–202;
Published: 10 December 2003
Abstract

Purpose: To determine if oocyte donors aged 36-39 can provide adequate pregnancy rates for recipients. Methods: Retrospective analysis of clinical, ongoing/delivered pregnancy and implantation rates for a group of recipients receiv­ing oocytes from a pilot group of older donors. Results: Comparable pregnancy and implantation rates were found in recipients transferring embryos derived from donors aged 36-39 as recipients using oocytes from donors ≤35. Conclusions: The demonstration of adequate outcome following embryo transfer from embryos derived from fertilization of oocytes from donors aged 36-39 should expand the pool of donor oocytes and reduce the long waiting times for recipients.

Keywords
Age
Recipient
In vitro fertilization
Share
Back to top